FDA Inspection 1228830 — New SPS Crossfolds, LLC

New SPS Crossfolds, LLC — FEI 3000285187

The FDA completed an inspection of New SPS Crossfolds, LLC on January 11, 2024 in Commack, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Commack, NY (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
126321 CFR 211.68(b)Computer control of master formula records
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
358521 CFR 211.110(a)Control procedures to monitor and validate performance
434221 CFR 211.142(b)Storage under appropriate conditions